<DOC>
	<DOCNO>NCT00752843</DOCNO>
	<brief_summary>This study determine effect single multiple oral dos mifepristone pharmacokinetics single oral dose fluvastatin administer healthy volunteer .</brief_summary>
	<brief_title>A Phase I Study Determine Effect Mifepristone Pharmacokinetics Fluvastatin Healthy Volunteers</brief_title>
	<detailed_description>This fixed-sequence , drug-drug interaction study healthy volunteer last total 9 week : 4 week screen , approximately 2 week dose ( include 1-week washout period ) , approximately 3 week drug-free interval termination . The purpose study determine effect single multiple oral dos CORLUX pharmacokinetics single oral dose fluvastatin administer healthy volunteer .</detailed_description>
	<mesh_term>Mifepristone</mesh_term>
	<mesh_term>Fluvastatin</mesh_term>
	<criteria>Male female healthy volunteer Body mass index ( BMI ) 1832 kg/m2 Female subject must negative serum pregnancy test result prior entry study All female subject must childbearing potential All male subject female partner childbearing potential must consent use medically acceptable doublebarrier method contraception donate sperm throughout study period least 3 month ( 90 day ) last dose study medication The subject agree abstain grapefruit grapefruit juice least 2 week prior first dose completion pharmacokinetic sampling ( Day 15 ) The subject must able provide write informed consent Any acute chronic disease state , include limited cardiovascular , dermatological , endocrine , gastrointestinal , hepatic , pulmonary , renal condition determine clinically significant Investigator Any clinically significant abnormal clinical laboratory test determine Investigator Any concomitant medication ( include prescription , overthecounter illicit ) within either 30 day five halflives ( whichever short ) prior dose Positive urine drug screen illicit drug Use tobacco nicotinecontaining product previous three month Grapefruit juice within two week prior first dose Participation clinical investigation drug , biological investigational therapy within 30 day prior dose Signs and/or symptom orthostatic hypotension , fatigue , anorexia , nausea , abdominal pain , joint muscle pain consider marker adrenal insufficiency History allergic reaction mifepristone fluvastatin Positive serum test human immunodeficiency virus ( HIV ) , hepatitis B virus hepatitis C virus Blood donation within 30 day dose</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>mifepristone</keyword>
	<keyword>CORLUX</keyword>
	<keyword>fluvastatin</keyword>
	<keyword>Lescol</keyword>
	<keyword>drug-drug interaction</keyword>
	<keyword>DDI</keyword>
	<keyword>pharmacokinetics</keyword>
</DOC>